Med device VC investing falls 9% in 2010

Venture capital investment in the medical device industry fell nine percent in 2010, ending the year as the fourth largest investment sector with $2.3 billion going into 324 deals. That's slightly more deals than in 2009, when medical devices ranked third among all industries. The figures were released today in a MoneyTree Report by PricewaterhouseCoopers and the National Venture Capital Association, based on data from Thomson Reuters. 

Medical devices had a particularly weak fourth quarter; the sector saw a drop of 31 percent in dollars and 15 percent in deals from Q3 2010 with $400 million going into 71 deals. The industry's biggest fundraiser in 2010 was DFINE, which garnered a $62 million round. The devicemaker is developing technologies that help patients with back pain due to spine fractures and other sources of bone pain. Trivascular ($60 million), Home Dialysis Plus ($50 million), Intrapace ($49.7 million) and PneumRx ($49.7 million) rounded out the top five fundraisers.

Overall, venture capitalists invested $21.8 billion in 3,277 deals in 2010, an increase of 19 percent in dollars and a 12 percent rise in deals over 2009.

- read the NVCA release

Suggested Articles

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.

Emmecell aims to make corneal transplant surgery, which can take up to a year to heal from and fails up to 20% of the time, a relic of the past.

Seven developers will provide digital health solutions aimed at the COVID-19 pandemic, including smartphone apps, wearables and big data programs.